AB
ABO antibodies
immunoprobe
hemocompatibility
antiantibody
ABO group
drozitumab
lorvotuzumab
patritumab
conatumumab
lintuzumab
immunotube
matuzumab
affinity
brentuximab
lexatumumab
ABO system
ABO blood group system
recognition
serology
radioimmunoelectrophoresis
naptumomab estafenatox
mapatumumab
panitumumab
immunopanning
polyantibody
immunoglobulin G
radioimmunology
complement fixation test
sibrotuzumab
complement
immunodecoration
immunofluorescence
antiustekinumab
antiserum
immunoadsorbent
tenatumomab
intetumumab
despeciation
seroclearance
oleclumab
immunorecognition
microlymphocytotoxicity
onartuzumab
fluorescein isothiocyanate
universal donor
pamrevlumab
fluorescein isocyanate
radioimmunoprecipitation
immunosorbent
affibody
antisynthetase
immunoadsorption
apolizumab
antiphospholipid antibody
sotrovimab
brentuximab vedotin
bivatuzumab
cibisatamab
potentiator
seroconversion
immunoaffinity
glembatumumab
glycoantigen